BWAY Brainsway Ltd

  1. Stocks
  2. Healthcare
  3. NASDAQ: BWAY

Price (delayed)

$14.23

Market cap

$557.33M

P/E Ratio

61.87

Dividend/share

N/A

EPS

$0.23

Enterprise value

$505.15M

?
Relative Growth: Rel. Growth: 87
Relative Strength: Rel. Strength: 90
Relative Valuation: Rel. Valuation: 30
Relative Profitability: Rel. Profitability: 92

brainsway is a leading global neurmodulation company with headquarters in jerusalem and the us. our patented breakthrough technology has already treated over 10,000 patients, and has helped usher in a ...

Highlights
BWAY's net income has soared by 124% YoY and by 16% QoQ
BWAY's EPS has surged by 92% year-on-year and by 15% since the previous quarter
BWAY's quick ratio is down by 39% year-on-year and by 12% since the previous quarter
The P/E is 26% higher than the last 4 quarters average of 48.4
Sector: Healthcare
Industry: Medical Devices
Website: http://brainsway.com
Peers: OBIO

Key stats

What are the main financial stats of BWAY

BWAY stock price

How has the Brainsway stock price performed over time
Intraday
1.35%
1 week
-10.39%
1 month
-13.34%
1 year
172.08%
YTD
49.63%
QTD
7.07%

Financial performance

How have Brainsway's revenue and profit performed over time
Revenue
$56.22M
Gross profit
$42.45M
Operating income
$5.75M
Net income
$8.76M
Gross margin
75.5%
Net margin
15.6%
Brainsway's operating margin has surged by 137% YoY and by 23% QoQ
BWAY's net income has soared by 124% YoY and by 16% QoQ
The company's net margin has surged by 73% YoY and by 8% QoQ
The operating income has grown by 33% from the previous quarter

Price vs fundamentals

How does BWAY's price correlate with its fundamentals

Growth

What is Brainsway's growth rate over time

Valuation

What is Brainsway stock price valuation
BWAY P/E details
P/E
61.87
P/B
7.35
P/S
9.91
EV/EBIT
46.78
EV/EBITDA
40.71
EV/Sales
8.99
BWAY's EPS has surged by 92% year-on-year and by 15% since the previous quarter
The P/E is 26% higher than the last 4 quarters average of 48.4
The P/B is 190% above the 5-year quarterly average of 2.5 and 48% above the last 4 quarters average of 4.9
The equity is up by 19% year-on-year and by 3.6% since the previous quarter
BWAY's P/S is 157% above its 5-year quarterly average of 3.8 and 44% above its last 4 quarters average of 6.8
The company's revenue rose by 29% YoY and by 8% QoQ

Efficiency

How efficient is Brainsway business performance
The ROE has soared by 65% YoY and by 11% from the previous quarter
The ROA has soared by 64% YoY and by 12% from the previous quarter
BWAY's return on sales is up by 36% year-on-year
BWAY's ROIC is down by 28% YoY and by 13% QoQ

Dividends

What is BWAY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BWAY.

Financial health

How did Brainsway financials performed over time
The total assets is 184% greater than the total liabilities
BWAY's quick ratio is down by 39% year-on-year and by 12% since the previous quarter
The current ratio has contracted by 34% YoY and by 10% from the previous quarter
The company's debt is 91% lower than its equity
The company's debt rose by 21% YoY
The equity is up by 19% year-on-year and by 3.6% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.